From: Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
Author | Study Population (pts) | Age (A/C) | Study duration | Adherence rate (%) |
---|---|---|---|---|
Chon (1993) [20] | 217 | A | 4 y | 50 |
Lower (1993) [21] | 315 | C | 4 y | 56 |
Tinkelman (1993) [22] | 3.349 | C,A | 1y | 65 |
Ruiz (1997) [23] | 247 | A | 18Â m | 62 |
Donahue (1999) [24] | 603 | C, A | 4y | 33 |
Rhodes (1999) [25] | 1.033 | A | 3y | 88 |
More & Hagan (2002) [26] | 381 | C,A | 3y | 77 |
Pajno (2005) [27] | 1.886 | C | 3y | 89 |
Hommers (2006) [28] | 296 | A | not stated | 66 |
Hankin (2008) [29] | 520 | C | 3y | 47 (1 y) 16 (3rd y) |
Mahesh (2010) [30] | 100 | A | not stated | 58 |
Hsu & Reisacher (2012) [31] | 139 | A | 4y | 55 |
Guenechea (2013) [32] | 156 | A | 5y | 63 |
Kiel (2013) [33] | 2.796 | A | 3y | 23 |
Silva (2014) [34] | 122 | C, A | 4y | 54 |